Skip to content

Phage therapy of multi-drug resistant pathogens in ventilator-associated pneumonia

Phage therapy of multi-drug resistant pathogens in ventilator-associated pneumonia

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300075709
Enrollment
Unknown
Registered
2023-09-13
Start date
2023-03-08
Completion date
Unknown
Last updated
2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ventilator-associated pneumonia

Interventions

Experimental group:The secretions of the lower respiratory tract of patients were collected for bacterial culture to obtain the information of major multi-drug-resistant pathogens. The sensitivity tes

Sponsors

Southern University of Science and Technology Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 95 Years

Inclusion criteria

Inclusion criteria: (1) Patients with multi-drug resistant bacterial infection (based on the drug sensitivity test results of our hospital or a third or higher hospital), except patients aged 0-95 with tumor and other diseases in the terminal stage who cannot benefit from treatment; (2) Pathogens infected by patients should meet one of the following conditions: 1) Pathogens resistant to key antibiotics (see the 12 superbugs defined by WHO 2017) 2) Pathogenic bacteria are sensitive to key antibiotics in vitro, but the antibiotic treatment is ineffective or ineffective (temperature, airway secretions, imaging, inflammation indicators and other indicators do not improve after 1 week of clinical use) 3) Limited use of critical sensitive antibiotics (patients with organ function impairment or allergy to antibiotics) (3) At least one phage matching with resistant bacteria can be screened (4) It can be administered by external application, spraying, atomizing inhalation, perfusion, local injection or catheter (5) The subjects and their family members (or guardians) fully read, understand and sign the informed consent

Exclusion criteria

Exclusion criteria: (1) Bacterial infections can be effectively controlled by antibiotic treatment (2) There is no effective way of administration other than intravenous administration (3) Exceeding the medical service load of the unit (4) Patients determined by the investigators to be unsuitable for participation in this study

Design outcomes

Primary

MeasureTime frame
Blood test index and imaging results;

Secondary

MeasureTime frame
Mechanical ventilation parameters;

Countries

China

Contacts

Public ContactYu Jialin

Hospital of Southern University of Science and Technology

yujialin486486@163.com+86 138 9606 9217

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026